Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

7.82
Delayed Data
As of Feb 12
 +0.56 / +7.71%
Today’s Change
5.30
Today|||52-Week Range
15.44
-24.08%
Year-to-Date
No recent news for Juniper Pharmaceuticals Inc.

Today’s Trading

Previous close7.26
Today’s open7.33
Day’s range7.33 - 7.83
Volume19,910
Average volume (3 months)49,906
Market cap$84.5M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-48.08%
Earnings growth (this year)-101.85%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+12.23%
P/E ratioNM
Price/Sales1.90
Price/Book2.06

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...+0.17+4.29%
CLCDCoLucid Pharmaceutic...-0.01-0.18%
--EcoGreen Internation...0.000.00%
SBBPStrongbridge Biophar...-0.01-0.26%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$32.5M
Annual profit (last year)$3.4M
Net profit margin10.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Frank C. Condella
Chief Operating Officer &
Director
Nikin Patel
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers